The effect of NAC in psychotic patients

Phase 3

Recruiting

• Conditions: Schizoaffective disorders is a medical classification as listed by WHO under the range - Mental, Behavioral and Neurodevelopmental disorders; Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances Psychotic disorder; F19.5; Condition 1: The schizophrenic disorders. Condition 2: Delusional disorders. Condition 3: Schizoaffective disorders. Condition 4: Mental and behavioural disorders.; The schizophrenic disorders are characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted; Delusional disorders is a medical classification as listed by WHO under the range - Mental, Behavioral and Neurodevelopmental disorders

• Registration Number: IRCT20240309061224N1
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Filling out the consent form by the patient's guardian and having consent for the patient to enter the research project
Being in the category of psychotic diseases : Participants had to meet criteria for a DSM-V psychotic disorder, including schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, depression with psychosis, substance-induced psychotic disorder.
The patient is not dangerous and does not pose a danger to herself or others

Exclusion Criteria

Dissatisfaction : Lack of consent, not filling out the consent form by the patient's guardian and not having consent for the patient to enter the research project
Being dangerous to yourself or others: The dangerousness of the patient and the high probability of having a risk of life and injury to oneself and others

Study & Design

• Study Type: interventional
• Study Design: Not specified